Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ALX Oncology Holdings (NASDAQ:ALXO) has initiated a Phase 2 investigator-sponsored study of evorpacept in combination with Eli Lilly’s (NYSE:LLY) ERBITUX (cetuximab) and Merck’s (NASDAQ:MRK) KEYTRUDA (pembrolizumab) in patients with refractory microsatellite stable metastatic colorectal cancer (mCRC).
Eli Lilly and Merck will provide ERBITUX, an anti-EGFR antibody and KEYTRUDA, an anti-PD-1 therapy to support this study.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
ALX Oncology underscored that the combination of a CD47 blocker with cetuximab and pembrolizumab acts through different but complementary mechanisms.
The company aims to see evorpacept in this triplet combination positively impact efficacy without increasing toxicity.
Wells Messersmith, M.D., Professor and Head of Medical Oncology at AGICC, commented: "In conjunction with AGICC, we are excited to initiate this study that builds upon the promising clinical activity and tolerability observed in patients with advanced solid tumors observed in ASPEN-01, ALX Oncology's phase 1b study. mCRC is a difficult-to-treat cancer and patients, particularly in the relapsed/refractory setting, will benefit from novel therapeutic options to help improve disease outcomes.”
The Colorectal cancer (CRC) starts in the colon or the rectum. These cancers can also be called colon cancer or rectal cancer, depending on where they start.
The company owns worldwide commercial rights to evorpacept.
Price Action : ALX Oncology shares are trading around 5 percent higher at $13.46 on Thursday at the time of publication.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.